By  Stephanie Locricchio

Legislators, students, community representatives and others will speak on the topic of informed consent at a health freedom rally at Rutgers University this Friday, May 21 at 11 a.m. ET, in protest of the university’s COVID vaccine mandate.

Since then, hundreds of universities — including the University of Notre Dame, Brown, Cornell, Northeastern University, New York’s State University (SUNY) and City University (CUNY) systems, and many other colleges and universities throughout the country — have said they will require COVID vaccines for the upcoming fall semester.

The Rutgers announcement prompted Robert F. Kennedy, Jr., Children’s Health Defense’s (CHD) chairman and chief legal counsel, to send a letter to Rutgers President Jonathan Holloway to remind him that mandating Emergency Use Authorization (EUA) products violates federal law.

By  Megan Redshaw

Research shows people with underlying health disorders or on immunosuppressive medications mount few antibodies to COVID vaccines, leading some to question if they should get the vaccine and, if so, what are the potential risks?

Emerging research shows that 15% to 80% of people with certain medical conditions aren’t generating many antibodies, if any, after receiving a COVID vaccine.

According to NBC News, people taking medications that suppress their immune system, those on medication for inflammatory disorders and those with blood cancers showed a significantly weaker antibody response to the vaccine.

An organ transplant study published in JAMA found 46% of 658 transplant patients did not mount an antibody response after two doses of the Pfizer-BioNTech or Moderna vaccines. Researchers think the lack of reaction is probably a result of taking a class of immunosuppressive drugs, called antimetabolites.

“Although this study demonstrates an improvement in…

By James Lyons-Weiler, PhD and Robert F. Kennedy, Jr.

The Vaccines and Related Biological Products Advisory Committee Briefing Document on the Pfizer-BioNTech COVID-19 vaccine contains disturbing indications that might be a safety signal on pathogenic priming, especially in older adults.

In the development of vaccines against coronaviruses like SARS-COV-1 and MERS in the early 2000’s, researchers found evidence of a serious problem. Teams of U.S. and foreign scientists vaccinated animals with the four most promising vaccines. At first, the experiment seemed successful as all the animals developed a robust antibody response to coronavirus. However, when the scientists exposed the vaccinated animals to the wild virus, the results were horrifying. Vaccinated animals suffered hyper-immune responses including inflammation throughout their bodies, especially in their lungs.

This issue is well known. Early in the COVID-19 scenario, Dr. Peter Hotez, of Baylor College of Medicine, testified before Congress about the dangers of accelerating…